SCHEMBL8626412

SCHEMBL8626412

COc1ccc(C2c3cc(C4Cc5ccccc5O4)ccc3CC2C(=O)O)cc1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 2/20 0.48
▸ GABRB2 P47870 2/20 0.48
▸ MAOB P27338 4/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ CYP19A1 P11511 4/20 0.44
▸ ABCG2 Q9UNQ0 2/20 0.44
▸ ABCB1 P08183 1/20 0.44
▸ AR P10275 1/20 0.44
▸ EDNRA P25101 3/20 0.44
▸ EDNRB P24530 2/20 0.44
▸ CYP3A4 P08684 1/20 0.42
▸ CYP1A1 P04798 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP1B1 Q16678 1/20 0.41
▸ LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7817290 0.81 EDNRA (0.61) GABRA1GABRB2EDNRAEDNRB
SCHEMBL13965005 0.77 MAOB (0.69) GABRA1GABRB2MAOBNPC1MAPT
SCHEMBL27456073 0.70 EDNRA (0.52) GABRA1GABRB2MAOBNPC1MAPT
SCHEMBL27324531 0.68 EDNRA (0.52) EDNRACYP3A4CYP1A2
SCHEMBL31125991 0.67 MAOB (0.65) GABRA1GABRB2MAOBNPC1MAPT
SCHEMBL25189215 0.66 GABRA1 (0.64) GABRA1GABRB2MAOBNPC1MAPT
SCHEMBL14966364 0.66 ALDH1A1 (0.56) MAOBNPC1MAPTRAB9ACYP19A1
SCHEMBL23320569 0.65 LMNA (0.54) MAOBCYP19A1ABCG2ABCB1AR
SCHEMBL23124236 0.65 HSP90AB1 (0.50) GABRA1GABRB2MAOBNPC1MAPT
SCHEMBL127704 0.65 MAOB (1.00) MAOBNPC1MAPTRAB9ACYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5817693-A Endothelin receptor antagonists SMITHKLINE BEECHAM CORPORATION 1998-10-06 — — US disclosed
US-5719183-A HYPOTENSIVE AGENTS; KIDNEY DISEASES; ANTIISCHEMIC AGENTS SMITHKLINE BEECHAM CORPORATION (US) 1998-02-17 — — US disclosed
US-5719182-A TREATING HYPERTENSION, RENAL FAILURE, CEREBROVASCULAR DISEASE SMITHKLINE BEECHAM CORPORATION (US) 1998-02-17 — — US disclosed
US-5716984-A INDANE AND INDENE DERIVATIVES; TREATMENT OF CARDIOVASCULAR DISORDERS, KIDNEY DISORDERS SMITHKLINE BEECHAM CORPORATION (US) 1998-02-10 — — US disclosed
Send feedback